Dernières nouvelles : Forger l’avenir de la DMLA et de l’OMD

LEARNING OBJECTIVES

At the end of this symposium, participants will be able to:

• Identify the critical unmet needs in neovascular AMD and DME management
• Demonstrate a comprehensive understanding of new therapeutic agents and their mechanism of action in nAMD and DME management
• Examine how to incorporate new therapeutic options into current management strategies for patients with nAMD and DME
• Apply new insights from multi-modal imaging platforms to optimize diagnosis and management in the retina clinic

CanMEDS Roles: Medical Expert, Scholar

SCIENTIFIC PLANNING COMMITTEE
Varun Chaudhary, MD, Chair
Arif Samad, MD
Sarah Mullen, MD
 

This symposium was co-developed with the Canadian Ophthalmological Society and Roche, in order to achieve scientific integrity, objectivity and balance.